MedPath

Treatment of Indigestion with Unani medicine Habb e Pachlona

Phase 3
Conditions
Health Condition 1: K30- Functional dyspepsia
Registration Number
CTRI/2023/05/052901
Lead Sponsor
Central Council for Research in Unani Medicine (CCRUM), New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients of either sex in the age group of 18-60

2. Patients meeting the Rome III diagnostic criteria for PDS

Exclusion Criteria

1. Presence of GI ulcer, erosive gastritis, atrophic gastritis, severe dysplasia of gastric mucosa or suspicious malignant lesion based on clinical diagnosis.

2. Having overlap syndrome combined with gastro esophageal reflux disease or irritable bowel syndrome

3. Having alarm symptoms (weight loss, black or tar stool, dysphasia, etc.)

4. Having any systemic disease (diseases of heart, lung, liver or kidney) or mental illness

5. History of surgery related with the gastrointestinal tract more than six months ago

6. Taking drugs which may affect the gastro intestinal tract, such as non-steroidal anti-inflammatory drugs and aspirin

7. Known Allergy to the experimental medications

8. Pregnant and breastfeeding

9. Refusing to sign the informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficacy will be assessed on the basis of assessment of patients clinically i.e. improvement in sign and symptomsTimepoint: At baseline and 14th day
Secondary Outcome Measures
NameTimeMethod
Haematological and biochemical assessment for safety assessmentTimepoint: At baseline and 14th day
© Copyright 2025. All Rights Reserved by MedPath